Related Experiment Video
Updated: Jun 3, 2026
04:41
Application of the En Bloc Concept Combined with Anatomic Resection in Laparoscopic Hepatectomy
Published on: March 10, 2023
Laparoscopic liver resection for hepatocellular carcinoma
Carmen D Chung1, Lydia L Lau, Kwan Lung Ko
1Department of Surgery, The University of Hong Kong, Hong Kong SAR.
Asian Journal of Surgery
|March 8, 2011
Summary
Laparoscopic liver resection for hepatocellular carcinoma (HCC) is safe, with acceptable oncologic outcomes, even in patients with cirrhosis. Further randomized trials are needed to compare it with open surgery.
Area of Science:
- Hepatobiliary Surgery
- Minimally Invasive Surgery
- Surgical Oncology
Background:
- Hepatocellular carcinoma (HCC) is a significant global health concern.
- Liver resection remains a primary curative treatment for resectable HCC.
- Laparoscopic liver resection (LLR) offers potential benefits over open surgery.
Purpose of the Study:
- To review the clinical experience and outcomes of laparoscopic liver resection for HCC.
- To analyze perioperative and oncologic results of LLR in HCC patients.
Main Methods:
- Comprehensive literature search of English papers on LLR for HCC up to May 2010.
- Analysis of 11 clinical studies including 466 patients.
- Comparison of patient characteristics, perioperative results, and oncologic outcomes.
Main Results:
- LLR was performed in 466 HCC patients, with 9% undergoing major resection.
- Mean operative time was 189.5 min, mean blood loss 315.6 mL; 14.6% required transfusion.
- Postoperative complications were generally low; 5-year disease-free survival ranged from 31-50%.
Conclusions:
- LLR for HCC appears safe and provides acceptable oncologic outcomes, even in cirrhotic livers.
- LLR demonstrated favorable survival rates comparable to open surgery.
- Randomized controlled trials are necessary to definitively compare LLR with conventional open surgery for HCC.
